The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review. - Wikidata - awgldk - TriplyDB

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

http://www.wikidata.org/entity/Q38111651

about

Hepatitis B virus therapy: What's the future holding for us?Recent advances of vaccine adjuvants for infectious diseases Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.Hepatitis B vaccine adverse events in China: risk control and regulation.Adjuvants for vaccines to drugs of abuse and addiction.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.Immunogenicity of a peptide-based anti-IgE conjugate vaccine in non-human primates.Hepatitis B vaccination: needs a revision.Recent progress concerning CpG DNA and its use as a vaccine adjuvant.Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.Prevention of hepatitis B virus infection: from the past to the future.Overview of Vaccine Adjuvants: Introduction, History, and Current Status.An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load.

P2860

Q26774198-C1432DDF-EB58-474D-9755-3FD984D62DE5 Q28083679-AAAEA2A1-4892-4B79-A914-17891F489F41 Q30388683-4935EF77-6CCA-462D-B010-C28918BC5FB7 Q33723418-AFCF8B7F-08A0-474A-BD34-F95ED24E4135 Q35493923-E969B9F3-E9B3-4581-BA18-F250C8CD83AB Q35826747-E7915670-ECDB-47C2-AD56-CA7062E7DE74 Q35853440-236EB071-9DCB-4F07-8E50-5C5D27AA4B32 Q36933639-A05EA730-FCDD-444B-B9EC-3572ECC15270 Q37699261-BD9A2F9B-478E-413D-90A3-6EAE0FCAE691 Q38168903-ED154B86-F325-4B40-913A-00368877AF1A Q38306933-9AC09CD9-7CA5-41B5-9CDB-C45998E80A63 Q38354222-BB11538E-7A4C-46B9-9EF9-EFB712F3AB0F Q38813523-70D83777-FDB4-4755-A4C2-2FC36D9B4F51 Q39174792-78A7432E-D5F1-4934-B51B-0B4880D8E7FE Q40067174-A34A03CB-3D0F-4F8F-A3FD-133A2CD60A08

P2860

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

http://www.wikidata.org/entity/Q38111651

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

@en

type

label

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

@en

prefLabel

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

@en

P1433

Q38111651-8F7545A9-B120-45B5-808E-6CD289F34172

P1476

Q38111651-C356D43E-94F8-472E-9D38-E559F2A91988

P2093

Q38111651-24BB2A70-6909-4D81-9613-011EB48BD42C

Q38111651-29D4D6B7-9B2A-468D-8434-B55D53EB48FA

Q38111651-9125D25D-7300-40B7-9460-D5E1D47B2711

Q38111651-ADA2A8BA-EACD-487B-9051-B9A1F3E61F0F

P2860

Q38111651-072F9A69-D6EE-47F7-A06C-8FBB18156F8A

Q38111651-0C0C9D80-56B5-43B4-A3BB-A36A52A397B6

Q38111651-1799139B-53C9-4F95-BFA2-F884A62247B8

Q38111651-1BAA97CF-15B7-465E-9EA3-564BB42BDF3B

Q38111651-225D4AFA-752E-4173-85F6-7E11F7E163D7

Q38111651-235D230B-5BCD-4313-BA39-B5040175B9B4

Q38111651-28274149-5E5D-4CC4-8688-FD6C0A0987DD

Q38111651-2B4113C9-BF14-4351-A42B-EED1D641E3EB

Q38111651-30918A77-56A9-4458-AB06-FD0DA8E23459

Q38111651-340D4E75-4DF6-407D-A0CD-5DD92DBB2C6A

P304

Q38111651-BF1514A2-B7D8-4588-951B-F80BCC87012B

P31

Q38111651-9135BC3D-C056-4443-AF73-5E8980822C6B

P356

Q38111651-23314702-3ECB-42CD-A3E2-38CC88212C46

P433

Q38111651-70284E69-BBFD-4CC4-B71E-CB1FD861D605

P478

Q38111651-6A90EBA9-A9E0-4AF5-BE58-2D250158E9FD

P577

Q38111651-A34DDC71-0E3B-456F-AAF6-D562BA1A489C

P5875

Q38111651-EB13B216-F023-4028-8511-5EE365C1E0C9

P698

Q38111651-2FDE03FA-C72B-4150-B79E-50A74EE37B7C

P932

Q38111651-AEE6BDA3-9BD4-4347-9CC2-2AFF7675FB87

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

@en

P2093

Francisco Diaz-Mitoma

http://www.w3.org/2001/XMLSchema#string

Nelson F Eng

http://www.w3.org/2001/XMLSchema#string

Nitin Bhardwaj

http://www.w3.org/2001/XMLSchema#string

Rebecca Mulligan

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

Stealth and cunning: hepatitis B and hepatitis C viruses.

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

Immunology of hepatitis B virus and hepatitis C virus infection

Molecular and cellular signatures of human vaccine adjuvants.

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.

Genomic analysis of the host response to hepatitis B virus infection.

Hepatitis B virus replication: novel roles for virus-host interactions.

P304

1661-1672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.24715

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237017093

http://www.w3.org/2001/XMLSchema#string

P698

23732907

http://www.w3.org/2001/XMLSchema#string

P932

3906263

http://www.w3.org/2001/XMLSchema#string